Nikhil Vivek Kamat, MD
Hematology/Oncology · Seattle
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
Offices
1 location · The Association of University Physicians · 3,484 clinicians in this group
Hospitals listed: Fred Hutchinson Cancer Center · Swedish Edmonds Hospital · University of Washington Medical Ctr. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Kamat’s office at (206) 288-1000 to ask if they take your plan before you enroll.
California Medical Board record
Licence A143715 · Delinquent
Licence status: Delinquent · since 2016 · expires 2023-10-31 · University of Southern California Keck School of Medicine.
License renewal fee has not been paid. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
State licence records
1 licence
- Washington MD.MD.60854854Physician And Surgeon License · since 2018 · expires 2028-10-04ActiveNo board action on this licenceCheck it with the state
We check Colorado, Delaware, Florida, Illinois, Maryland, New Jersey, New York, Tennessee, Texas, Virginia, Washington, plus California above. A state that is not in this list has not been checked, which is not the same as clear.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Swedish Edmonds HospitalEdmonds, WAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Providence, which runs 54 hospitals in 7 statesPatients rate it 3 of 5 · 61% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.427, Oct 2024 – Sep 2025
- University of Washington Medical CtrSeattle, WAAcute Care Hospital · Government - State · No emergency department · Birthing-friendlyPart of UW Medicine, which runs 4 hospitalsHome of Fred Hutchinson / University of Washington / Seattle Children's Cancer Consortium, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Postoperative respiratory failure rate: 4.94 (1.58 to 8.3) · 2,791 cases, Jul 2022 – Jun 2024Better than the national rate — Postoperative sepsis rate: 2.48 (0.42 to 4.54) · 3,047 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0.42, Oct 2024 – Sep 2025Better than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 8.1 (6 to 10.6) · 540 cases, Jan 2024 – Dec 2024Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,118 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for Swedish Edmonds Hospital
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 0 better, 6 the same, 0 worse of 6 measures. Readmissions: 0 better, 6 the same, 1 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.427 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.87 (0 to 1.87) · 589 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.88 (0.5 to 1.26) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 6.4 · 68 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.7 · 102 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.5 · 275 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 265 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 12.4 · 296 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.5 · 2,364 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.17 (0 to 0.38) · 3,533 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.07 to 0.48) · 3,529 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.45 (1.14 to 5.75) · 556 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.6 (0 to 3.3) · 144 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.1 (0.45 to 3.74) · 508 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.24 (0 to 16.18) · 143 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.34 (1.31 to 9.37) · 118 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.65 (0.17 to 3.13) · 164 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.47 (0 to 1.26) · 2,935 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.423 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.093 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.574 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.212 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14 · 194 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.5 · 498 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -8.2 · 90 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -16.2 · 302 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 34.3 · 262 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 433 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 21.5 · 158 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.6 (9.6 to 16.8) · 796 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.6) · 207 cases | No different | Jan 2024 – Dec 2024 |
What patients said (396 patients answered, 17% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 2 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 75% |
| Doctors "always" communicated well | 76% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 74% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 61% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 71% |
| Nurses "always" listened carefully | 72% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 61% |
| Staff "always" explained possible side effects | 39% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
See every measure and the patient survey for University of Washington Medical Ctr
Behind the star rating — Deaths: 1 better, 7 the same, 0 worse of 8 measures. Safety: 1 better, 7 the same, 0 worse of 8 measures. Readmissions: 3 better, 7 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Postoperative respiratory failure rateComplications and deaths | 4.94 (1.58 to 8.3) · 2,791 cases | Better | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 2.48 (0.42 to 4.54) · 3,047 cases | Better | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.42 | Better | Oct 2024 – Sep 2025 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 8.1 (6 to 10.6) · 540 cases | Better | Jan 2024 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.8 (0.7 to 1) · 2,118 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.41 to 1.87) · 3,356 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.87 (0.68 to 1.06) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 171.77 (137.68 to 205.86) · 295 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 33 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.3 · 123 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.6 · 169 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.4 · 643 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.6 · 522 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 256 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.6 · 5,179 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.14 to 0.48) · 12,916 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.31 (0.14 to 0.48) · 13,941 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.81 (2.43 to 5.19) · 5,095 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 0.99 (0 to 2.05) · 3,007 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.24 (2.26 to 4.23) · 4,648 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.45 to 3.02) · 1,296 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.85 (0.42 to 1.28) · 11,531 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.9 · 136 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 1.227 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 1.165 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.919 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 1.72 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.262 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 13.7 · 288 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.2 · 887 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -17.4 · 213 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -32.1 · 730 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 12 · 543 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.2 · 649 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5 (3.6 to 6.8) · 540 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.6 · 138 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.5 · 34 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 173 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.9 (10.1 to 16.3) · 2,084 cases | No different | Jan 2022 – Dec 2024 |
What patients said (4,925 patients answered, 24% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 80% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 90% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 75% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
Original Medicare doctor bills
$112,278
Medicare paid this office $112,278 for 247 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 100 | $54,278 | $121 |
| Return visit (30+ min) | 122 | $23,481 | $79 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 193 | $10,197 | $14 |
| New patient visit (60+ min) | 30 | $4,718 | $157 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $4,667 | $146 |
See all 11 services
| Long return visit (40+ min) | 100 | $54,278 | $121 |
| Return visit (30+ min) | 122 | $23,481 | $79 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 193 | $10,197 | $14 |
| New patient visit (60+ min) | 30 | $4,718 | $157 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $4,667 | $146 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $3,645 | $104 |
| New patient visit (45+ min) | 18 | $2,123 | $118 |
| Telephone medical discussion with physician, 11-20 minutes | 27 | $2,026 | $53 |
| Short return visit (20+ min) | 31 | $1,828 | $49 |
| Telephone medical discussion with physician, 5-10 minutes | 33 | $1,515 | $28 |
| Telephone medical discussion with physician, 21-30 minutes | 15 | $1,180 | $79 |
Who their Medicare patients are
247 Original Medicare patients in 2024. Average age 74 · Under 65 7% · 85 and older 13% · Women 48% · Also on Medicaid 13% · Health risk score 2.14. Above the middle of the specialty; the typical hematology-oncology clinician is at 2.04.
Conditions among them: High blood pressure 65% · Cancer 59% · Coronary heart disease 28% · Diabetes 25% · Chronic kidney disease 25% · Depression 23% · Atrial fibrillation 21% · COPD 17% · Heart failure 16% · Stroke 10% · Dementia 7%.
The office billed $415,470, Medicare allowed $147,137 and paid $112,278; for 1,771 services of 16 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 247 | 1,771 | 74 | 2.14 | $415,470 | $112,278 |
| 2023 | 255 | 1,094 | 74 | 1.93 | $351,202 | $106,694 |
| 2022 | 198 | 787 | 74 | 1.59 | $246,357 | $86,765 |
| 2021 | 66 | 142 | 73 | 1.34 | $46,769 | $17,564 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| Long return visit (40+ min) | 120 | $67,289 | $118 |
| Return visit (30+ min) | 118 | $17,337 | $75 |
| New patient visit (60+ min) | 31 | $4,496 | $145 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,413 | $142 |
| New patient visit (45+ min) | 31 | $3,108 | $100 |
| Short return visit (20+ min) | 39 | $2,714 | $51 |
| Telephone medical discussion with physician, 11-20 minutes | 37 | $2,431 | $57 |
| Telephone medical discussion with physician, 5-10 minutes | 49 | $1,886 | $29 |
2022: 8 services
| Long return visit (40+ min) | 107 | $53,243 | $119 |
| New patient visit (60+ min) | 69 | $10,061 | $146 |
| Return visit (30+ min) | 59 | $8,019 | $78 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 28 | $5,508 | $167 |
| New patient visit (45+ min) | 29 | $3,072 | $106 |
| Telephone medical discussion with physician, 21-30 minutes | 14 | $1,503 | $83 |
| Telephone medical discussion with physician, 11-20 minutes | 14 | $1,298 | $54 |
| Short return visit (20+ min) | 23 | $1,237 | $48 |
2021: 3 services
| Long return visit (40+ min) | 38 | $8,983 | $125 |
| New patient visit (60+ min) | 34 | $5,415 | $159 |
| Return visit (30+ min) | 16 | $1,460 | $81 |
Medicaid work
$3,932 in 2024
Medicaid paid $3,932 for 155 billed services this clinician did in 2024, up to 17 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Long return visit (40+ min) | 70 | $2,418 |
| Return visit (30+ min) | 57 | $1,425 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | 28 | $89 |
| 2024 | 155 | 3 | 17 | $3,932 |
| 2023 | 129 | 2 | 16 | $5,437 |
| 2022 | 57 | 1 | 17 | $2,762 |
See the largest Medicaid services in earlier years
2023
| Long return visit (40+ min) | 116 | $5,066 |
| Return visit (30+ min) | 13 | $371 |
2022
| Long return visit (40+ min) | 57 | $2,762 |
Drugs they prescribed that Part D paid
$1,730,474
Pharmacies billed $1,730,474 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 5% of their Part D prescriptions (79 of 1,770) in 2024. At or below the middle of the specialty; the typical hematology-oncology clinician is at 5%. Long-acting opioids: 28% of their opioid prescriptions.
1,498 generic and fewer than 11 brand-name prescriptions · $1,730,474 in drug cost · 32 antibiotic prescriptions to 19 people · 15 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Lenalidomide | 30 | $419,220 | $13,974 |
| Xtandi | 15 | $213,104 | $14,207 |
| Eliquis | 101 | $71,544 | $708 |
| Orgovyx | 22 | $57,192 | $2,600 |
| Xarelto | 37 | $43,817 | $1,184 |
See all 34 drugs
| Lenalidomide | 30 | $419,220 | $13,974 |
| Xtandi | 15 | $213,104 | $14,207 |
| Eliquis | 101 | $71,544 | $708 |
| Orgovyx | 22 | $57,192 | $2,600 |
| Xarelto | 37 | $43,817 | $1,184 |
| Abiraterone Acetate | 79 | $38,631 | $489 |
| Letrozole | 122 | $3,024 | $25 |
| Gabapentin | 143 | $1,347 | $9 |
| Prochlorperazine Maleate | 69 | $1,270 | $18 |
| Exemestane | 11 | $1,240 | $113 |
| Ondansetron | 84 | $853 | $10 |
| Anastrozole | 34 | $745 | $22 |
| Valacyclovir | 14 | $643 | $46 |
| Acyclovir | 46 | $617 | $13 |
| Dexamethasone | 35 | $603 | $17 |
| Prednisone | 119 | $544 | $5 |
| Tamoxifen Citrate | 22 | $533 | $24 |
| Potassium Chloride | 47 | $492 | $10 |
| Morphine Sulfate Er | 22 | $470 | $21 |
| Hydroxyurea | 20 | $402 | $20 |
| Oxycodone | 35 | $398 | $11 |
| Losartan | 36 | $351 | $10 |
| Lidocaine-Prilocaine | 23 | $329 | $14 |
| Tamsulosin | 36 | $303 | $8 |
| Famotidine | 32 | $284 | $9 |
| Loperamide | 17 | $170 | $10 |
| Omeprazole | 19 | $154 | $8 |
| Levothyroxine | 20 | $143 | $7 |
| Amlodipine Besylate | 13 | $137 | $11 |
| Sulfamethoxazole-Trimethoprim | 15 | $130 | $9 |
| Tizanidine | 15 | $120 | $8 |
| Olanzapine | 13 | $101 | $8 |
| Pantoprazole | 11 | $90 | $8 |
| Atorvastatin | 17 | $74 | $4 |
Year by year
| 2024 | 1,770 | 211 | 5% (79) | None | $1,730,474 |
| 2023 | 1,335 | 176 | 5% (68) | 12% | $887,918 |
| 2022 | 719 | 133 | 7% (47) | None | $257,588 |
| 2021 | 87 | 35 | 29% (25) | 16% | $31,007 |
| 2020 | 26 | None | None | None | $9,790 |
| 2019 | 75 | 25 | None | 27% | $65,649 |
| 2018 | 27 | None | None | None | $1,299 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 29 drugs
| Lenalidomide | 16 | $224,808 | $14,051 |
| Calquence | 11 | $176,214 | $16,019 |
| Eliquis | 43 | $36,161 | $841 |
| Xarelto | 37 | $36,098 | $976 |
| Abiraterone Acetate | 76 | $30,737 | $404 |
| Enoxaparin | 13 | $11,575 | $890 |
| Letrozole | 87 | $3,752 | $43 |
| Exemestane | 14 | $1,908 | $136 |
| Ondansetron | 75 | $1,479 | $20 |
| Prochlorperazine Maleate | 68 | $1,315 | $19 |
| Loperamide | 36 | $1,300 | $36 |
| Dexamethasone | 51 | $1,130 | $22 |
| Anastrozole | 30 | $1,031 | $34 |
| Acyclovir | 49 | $1,007 | $21 |
| Potassium Chloride | 28 | $696 | $25 |
| Hydroxyurea | 16 | $684 | $43 |
| Lidocaine-Prilocaine | 29 | $597 | $21 |
| Prednisone | 93 | $586 | $6 |
| Gabapentin | 57 | $502 | $9 |
| Olanzapine | 28 | $439 | $16 |
| Hydrocodone-Acetaminophen | 12 | $324 | $27 |
| Oxycodone | 24 | $302 | $13 |
| Diphenoxylate-Atropine | 13 | $287 | $22 |
| Pantoprazole | 15 | $240 | $16 |
| Losartan | 19 | $164 | $9 |
| Tamsulosin | 19 | $159 | $8 |
| Famotidine | 28 | $158 | $6 |
| Lorazepam | 16 | $75 | $5 |
| Metformin Hcl Er | 11 | $63 | $6 |
2022: 18 drugs
| Xarelto | 43 | $29,571 | $688 |
| Eliquis | 37 | $25,485 | $689 |
| Abiraterone Acetate | 26 | $19,958 | $768 |
| Ondansetron | 45 | $1,084 | $24 |
| Prochlorperazine Maleate | 38 | $827 | $22 |
| Letrozole | 28 | $742 | $27 |
| Loperamide | 18 | $509 | $28 |
| Prednisone | 58 | $507 | $9 |
| Lidocaine Hcl Viscous | 24 | $456 | $19 |
| Gabapentin | 24 | $451 | $19 |
| Klor-Con M20 | 16 | $418 | $26 |
| Dexamethasone | 31 | $385 | $12 |
| Anastrozole | 11 | $380 | $35 |
| Acetaminophen-Codeine | 16 | $319 | $20 |
| Oxycodone | 16 | $293 | $18 |
| Lidocaine-Prilocaine | 13 | $271 | $21 |
| Losartan | 19 | $95 | $5 |
| Tamsulosin | 12 | $91 | $8 |
2021: 1 drug
| Oxycodone | 11 | $213 | $19 |
Money from drug and device companies
$364 in 2024
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | None | $350 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | None | $14 | 1 payment
|
See all 2 published payments
| AstraZeneca Pharmaceuticals LP | Grant · 2024-09-04 | None | $350 |
| E.R. Squibb & Sons L.L.C. | Education · 2024-07-05 | None | $14 |
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 93.1 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1922493014
- Licence
- CA A143715, WA MD60854854California A143715: Delinquent · expires 2023-10-31Washington MD.MD.60854854: Active
- Trained
- University of Southern California Keck School of Medicine, 2015
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RH0003X (207RH0003X); Internal medicine (207R00000X); Student in a training program (390200000X)
- Mailing address
- Po Box 50095, Seattle, WA, 98145
- NPI first listed
- 2015-04-06
- NPI last updated
- 2021-05-18
- NPI record certified
- 2021-05-18
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 300 Pasteur Dr Ofc Lane154, Stanford, CA, 94305